Effect of risperidone in breath-holding
Phase 2
Completed
- Conditions
- breath-holding.Other abnormalities of breathingR06.89
- Registration Number
- IRCT20200203046350N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
having experienced one or more breath-holding attack
Exclusion Criteria
Patients with a history of seizure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of breath-holding attack. Timepoint: Before treatment to three months after treatment. Method of measurement: Number of breath-holding attacks based on observation.;Breath holding grade. Timepoint: Before treatment to three months after treatment. Method of measurement: breath-holding grade based on observation.
- Secondary Outcome Measures
Name Time Method